MROPF.US MicroPort CardioFlow Medtech Corporation

Healthcare Medical Devices USA Stocks
0.6465 USD
Close of Nov 12, 2026
0.6465 0.6465
Market cap
USD 823M
P/E
-
P/B
1.04x
ROE
-7.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is MROPF.US undervalued?

Graham number

The Graham number of MicroPort CardioFlow Medtech Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MicroPort CardioFlow Medtech Corporation fundamental analysis

No fundamental analysis for MicroPort CardioFlow Medtech Corporation yet.

MicroPort CardioFlow Medtech Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MicroPort CardioFlow Medtech Corporation

MicroPort CardioFlow Medtech Corporation, together with its subsidiaries, researches, develops, manufactures, and sells medical devices for the treatment of structural heart disease and cardiac rhythm management in China, Europe, the Middle East, Africa, Asia, North America, and internationally. The company offers VitaFlow, a transcatheter aortic valve system; VitaFlow Liberty, a transcatheter aortic valve retrievable and controllable bend delivery system; Alwide, a plus val…

Full company profile